What does CUSIP 53630L100 represent in this 13F holders report?

CUSIP 53630L100 is the security identifier for LIPO - LIPELLA PHARMACEUTICALS INC. - Common Stock used to aggregate holder disclosures.

How many institutions held LIPO - LIPELLA PHARMACEUTICALS INC. - Common Stock in Q1 2024?

9 institutional investors reported LIPO - LIPELLA PHARMACEUTICALS INC. - Common Stock for Q1 2024. Use the holders table for investor-level position and value details.

LIPELLA PHARMACEUTICALS INC. - Common Stock (LIPO)

CUSIP: 53630L100

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock
Total 13F shares: 379,795
Total 13F value: $260,082
Share change: +9,782
SEC-reported price per share: $0.68
Number of holders: 9
Value change: +$6,368
Number of buys: 5
Number of sells: 3
Shares outstanding: 1,231,122

Security key

53630L100

Report period

Q1 2024

Institutions

Top holders

LIPO full security history Ownership snapshot Full 13F holder table LIPELLA PHARMACEUTICALS INC. SEC filings LIPELLA PHARMACEUTICALS INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of LIPO - LIPELLA PHARMACEUTICALS INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

SABBY MANAGEMENT, LLC

Disclosed value leader

Michael B. Chancellor

Comparable rows

7/15

Latest evidence

15 Mar 2024

13F 3/4/5 Lead comparable stake: 22% 8 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 22%.

7 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SABBY MANAGEMENT, LLC's linked filing trail.

Comparable ownership Top 5

SABBY MANAGEMENT, LLC 22%

GEODE CAPITAL MANAGEMENT, LLC 3.4%

VANGUARD GROUP INC 2.8%

TWO SIGMA INVESTMENTS, LP 1.3%

Tower Research Capital LLC (TRC) 0.56%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SABBY MANAGEMENT, LLC	13F Company 13F	22%	$275,226 269,829 shares	—	31 Dec 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	3.4%	$42,931 42,090 shares	—	31 Dec 2023
VANGUARD GROUP INC	13F Company 13F	2.8%	$35,210 34,520 shares	—	31 Dec 2023
TWO SIGMA INVESTMENTS, LP	13F Company 13F	1.3%	$16,182 15,865 shares	—	31 Dec 2023
Tower Research Capital LLC (TRC)	13F Company 13F	0.56%	$7,057 6,919 shares	—	31 Dec 2023
UBS Group AG	13F Company 13F	0.06%	$776 761 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

379,795

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %